Study discovers link between a breakdown product from excess

Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.

Related Keywords

United States , Stanley Hazen , Jan Bleeksma , Marc Ferrell , Vascular Thoracic Institute , National Institutes Of Health , Human Health , Cleveland Clinic Lerner Research Institute , Cleveland Clinic Center , Metabolic Sciences , Cleveland Clinic , Lerner Research Institute , Co Section Head , Preventive Cardiology , Jan Bleeksma Chair , Vascular Cell Biology , Case Western Reserve University , Medical Scientist Training Program , National Institutes , Heart , Heart Disease , Niacin , Aging , Atherosclerosis , Flood , Blood Vessels , Ardiology , Cardiovascular Disease , Fell , Cell Biology , Cholesterol , Hronic , Iagnostic , Diet , Drugs , Fruit , Enetic , Heart Attack , Inflammation , Inflammatory Disease , Laboratory , Medicine , Etabolites , Icrobiome , Ortality , Mh , Reclinical , Research , Stroke , Supplements , Herapeutics , Ascular , Vegetables , Vitamin B ,